4/A: Paychex Executive Corrects Stock Grant Reporting Error in Amended SEC Filing
SEC Filing
Michael E. Gioja, a Senior Vice President at Paychex, filed an amended Form 4/A to correct an underreported number of performance shares granted.
Summary
- Michael E. Gioja, a Senior Vice President at Paychex, filed an amended Form 4/A with the SEC.
- The filing corrects an administrative error related to the number of performance shares granted, which was underreported in the initial Form 4 filing.
- The original transaction date was July 15, 2024, and the amendment was filed on August 6, 2024.
- The filing also includes details of Gioja's direct and indirect ownership of Paychex common stock and stock options.
- Gioja directly owns 21,010 stock options exercisable at $120.86, expiring on July 14, 2033.
- He also owns various other stock options with different exercise prices and expiration dates.
- Additionally, Gioja indirectly owns 3,463 shares of common stock through a family trust.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. The correction of the error is a positive sign of attention to detail.
Positives
- The filing corrects a previous error, ensuring accurate reporting of executive stock ownership.
- The document provides transparency regarding the executive's holdings in the company.
Industry Context
Executive stock ownership and trading activity are closely monitored in the financial industry as they can provide insights into management's confidence in the company's prospects. These filings are standard practice and provide transparency to investors.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common across publicly traded companies like Paychex.
- Companies such as ADP and Intuit, which operate in similar sectors, also grant stock options to their executives as part of their compensation strategy.
- The specific terms and amounts of these grants vary based on company size, performance, and industry benchmarks.
Stakeholder Impact
- The correction of the reporting error ensures that shareholders have accurate information regarding executive stock ownership.
- This promotes transparency and trust in the company's governance.
Key Dates
| Date | Description |
|---|---|
| 07/12/2018 | Date exercisable for stock options with an exercise price of $57.24 and an expiration date of 07/11/2027. |
| 07/11/2019 | Date exercisable for stock options with an exercise price of $69.54 and an expiration date of 07/10/2028. |
| 07/10/2020 | Date exercisable for stock options with an exercise price of $85.46 and an expiration date of 07/09/2029. |
| 07/15/2021 | Date exercisable for stock options with an exercise price of $73.53 and an expiration date of 07/14/2030. |
| 07/15/2022 | Date exercisable for stock options with an exercise price of $112.67 and an expiration date of 07/14/2031. |
| 07/15/2023 | Date exercisable for stock options with an exercise price of $115 and an expiration date of 07/14/2032. |
| 07/15/2024 | Date of the earliest transaction and date exercisable for stock options with an exercise price of $120.86 and an expiration date of 07/14/2033. |
| 07/15/2025 | Date exercisable for stock options with an exercise price of $121.63 and an expiration date of 07/14/2034. |
| 10/22/2026 | Expiration date of Dana L Bolia's Notary Public commission. |
| 07/11/2027 | Expiration date for stock options with an exercise price of $57.24. |
| 07/10/2028 | Expiration date for stock options with an exercise price of $69.54. |
| 07/09/2029 | Expiration date for stock options with an exercise price of $85.46. |
| 07/14/2030 | Expiration date for stock options with an exercise price of $73.53. |
| 07/14/2031 | Expiration date for stock options with an exercise price of $112.67. |
| 07/14/2032 | Expiration date for stock options with an exercise price of $115. |
| 07/14/2033 | Expiration date for stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for stock options with an exercise price of $121.63. |
| 08/01/2024 | Date of execution for the Limited Power of Attorney. |
| 08/06/2024 | Date of the amended filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.